EVIS LUCERA ULTRASONIC BRONCHOFIBERVIDEOSCOPE BF-UC260FW

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2018-12-27 for EVIS LUCERA ULTRASONIC BRONCHOFIBERVIDEOSCOPE BF-UC260FW manufactured by Olympus Medical Systems Corp..

Event Text Entries

[131593887] The subject device in this report has not been returned to omsc for evaluation. The exact cause of the reported event could not be conclusively determined at this time. If additional information becomes available, this report will be supplemented.
Patient Sequence No: 1, Text Type: N, H10


[131593888] Olympus medical systems corp. (omsc) was informed that four olympus bronchoscopes had been quarantined by the infection control department of the user facility due to detections of microbiological contamination in samples of patients. Olympus followed up with the user facility to obtain the detail of the event. It was reported that the biopsy samples collected from four patients were contaminated with cupriavidus, elizabethkingia miricola, or delftia acidovorans after bronchoscopy using four olympus bronchoscopes at the user facility as follows; first patient: the patient contaminated with cupriavidus after bronchoscopy using bf-1t260 (s/n (b)(4)). Second patient: the patient contaminated with cupriavidus after bronchoscopy using bf-uc260fw (s/n (b)(4)). Third patient: the patient contaminated with delftia acidovorans after bronchoscopy using bf-260 (s/n (b)(4)). Fourth patient: the patient contaminated with delftia acidovorans after bronchoscopy using bf-260 (s/n (b)(4)). The bronchoscopes had been reprocessed using a non-olympus automated endoscope reprocessor (bht) with peracetic acid after manual reprocessing. It was reported that it possibly took up 12 hours for the bronchoscopes to be reprocessed between the bedside cleaning at the user facility and the manual cleaning at a third party decontamination facility. It was reported that the bronchoscopes were packed in the surestore system (non-olympus equipment) at the third party decontamination facility. The surestore system is vacuum pack system that add 5% of hydrogen peroxide inside the endoscope channel. The user facility conducted a microbiological testing for the bf-uc260fw at (b)(6). As a result of testing, no microbe was detected from the sample collected from the bf-uc260fw. The conditions of four patients are currently unknown. This is two of four reports on infection associated with the bf-uc260fw.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8010047-2018-02595
MDR Report Key8201848
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2018-12-27
Date of Report2019-02-06
Date of Event2018-11-29
Date Mfgr Received2019-01-08
Device Manufacturer Date2013-07-12
Date Added to Maude2018-12-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR KAZUTAKA MATSUMOTO
Manufacturer Street2951 ISHIKAWA-CHO
Manufacturer CityHACHIOJI-SHI, TOKYO-TO 192-8507
Manufacturer CountryJA
Manufacturer Postal192-8507
Manufacturer Phone426425177
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEVIS LUCERA ULTRASONIC BRONCHOFIBERVIDEOSCOPE
Generic NameULTRASONIC BRONCHOFIBERVIDEOSCOPE
Product CodePSV
Date Received2018-12-27
Model NumberBF-UC260FW
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerOLYMPUS MEDICAL SYSTEMS CORP.
Manufacturer Address2951 ISHIKAWA-CHO HACHIOJI-SHI, TOKYO-TO US


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-12-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.